We are currently conducting a study of the educational impact of this podcast and highly welcome your voluntary participation. To participate, please visit: ⁠https://redcap.link/lcpod⁠


In this episode, hosts Anita Chopra, Andrew Schamess, Aaron Friedberg, and Carissa Lee are joined by Dr. Michal Tal to discuss groundbreaking immunoengineering research that could redefine Long COVID diagnosis. Dr. Tal leads the MAESTRO study, the largest clinical study at MIT, in hopes of improving our understanding of chronic illnesses like Long COVID and Lyme Disease. Through extensive multimodal profiling, her work uncovers hidden cellular and vascular changes, offering patients more objective answers and targeted treatments. She describes how advanced techniques like capillaroscopy and molecular profiling are transforming vague symptoms into measurable data, moving away from stigma towards validated science. The episode concludes with Dr. Tal's reflections on the importance of accessible language and storytelling in research communication.


Read more about Dr. Tal's research here: https://talresearchgroup.mit.edu/


Edited and Produced by Christopher Chiu and Carissa Lee

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Christopher Chiu, Andrew Schamess, Anita Chopra, Tiffany Walker, Aaron Friedberg. Innehållet i podden är skapat av Christopher Chiu, Andrew Schamess, Anita Chopra, Tiffany Walker, Aaron Friedberg och inte av, eller tillsammans med, Poddtoppen.